USAID, U.S. Pharmacopeia Supporting Efforts To Develop Test To Detect Fake, Substandard Medicines

Wall Street Journal: A New Way to Detect Fake Medicines
“…Fake, substandard, and otherwise compromised medicines are a deadly global problem. For Pakistan-born bioengineer Muhammad Zaman, the crisis in Lahore [in which more than 200 people died from contaminated medicine in 2011-12], … was an extra catalyst to continue efforts that he’d embarked upon the previous year — by invitation from the U.S. Agency for International Development and in partnership with U.S. Pharmacopeia, which sets medical standards used worldwide — to find a novel way to detect such medicines before they harm patients…” (Bloch, 1/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.